TIGERMED Repurchases 0.54 Million A-Shares, Trimming Free Float by 0.08%

Bulletin Express

06/18

Hangzhou Tigermed Consulting Co., Ltd. (TIGERMED) disclosed a share repurchase executed on 18 June 2026 via the Shenzhen Stock Exchange, acquiring 542,400 A-shares at prices ranging from RMB 39.33 to RMB 39.98 per share. The volume-weighted average repurchase price was RMB 39.85, bringing total cash outflow to approximately RMB 21.62 million.

Following the transaction, TIGERMED’s outstanding A-shares (excluding treasury shares) decreased by 0.08% from 713.40 million to 712.86 million. Concurrently, treasury shares rose from 24.50 million to 25.04 million, while the company’s total issued share count remained unchanged at 737.90 million.

The shares were retained as treasury stock; no cancellations were reported as of the 18 June 2026 closing balance date. The company confirmed that the repurchase complied with Shenzhen Stock Exchange regulations and related Hong Kong Stock Exchange rules governing share buybacks.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1103580602"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1103580602\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1103580602?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-18 17:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1103580602","market":"hk","top_or_hot":-1,"title":"TIGERMED Repurchases 0.54 Million A-Shares, Trimming Free Float by 0.08%","media":"Bulletin Express","content":"<p>Hangzhou Tigermed Consulting Co., Ltd. (TIGERMED) disclosed a share repurchase executed on 18 June 2026 via the Shenzhen Stock Exchange, acquiring 542,400 A-shares at prices ranging from RMB 39.33 to RMB 39.98 per share. The volume-weighted average repurchase price was RMB 39.85, bringing total cash outflow to approximately RMB 21.62 million.</p>\n<p>Following the transaction, TIGERMED’s outstanding A-shares (excluding treasury shares) decreased by 0.08% from 713.40 million to 712.86 million. Concurrently, treasury shares rose from 24.50 million to 25.04 million, while the company’s total issued share count remained unchanged at 737.90 million.</p>\n<p>The shares were retained as treasury stock; no cancellations were reported as of the 18 June 2026 closing balance date. The company confirmed that the repurchase complied with Shenzhen Stock Exchange regulations and related Hong Kong Stock Exchange rules governing share buybacks.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TIGERMED Repurchases 0.54 Million A-Shares, Trimming Free Float by 0.08%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTIGERMED Repurchases 0.54 Million A-Shares, Trimming Free Float by 0.08%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-18 17:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hangzhou Tigermed Consulting Co., Ltd. (TIGERMED) disclosed a share repurchase executed on 18 June 2026 via the Shenzhen Stock Exchange, acquiring 542,400 A-shares at prices ranging from RMB 39.33 to RMB 39.98 per share. The volume-weighted average repurchase price was RMB 39.85, bringing total cash outflow to approximately RMB 21.62 million.</p>\n<p>Following the transaction, TIGERMED’s outstanding A-shares (excluding treasury shares) decreased by 0.08% from 713.40 million to 712.86 million. Concurrently, treasury shares rose from 24.50 million to 25.04 million, while the company’s total issued share count remained unchanged at 737.90 million.</p>\n<p>The shares were retained as treasury stock; no cancellations were reported as of the 18 June 2026 closing balance date. The company confirmed that the repurchase complied with Shenzhen Stock Exchange regulations and related Hong Kong Stock Exchange rules governing share buybacks.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03347","symbol_name":"泰格医药","start_time":0,"source_url":"","article_id":"1103580602","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1103580602","pubTimestamp":1781773554,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hangzhou Tigermed Consulting Co., Ltd. (TIGERMED) disclosed a share repurchase executed on 18 June 2026 via the Shenzhen Stock Exchange, acquiring 542,400 A-shares at prices ranging from RMB 39.33 to...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03347":"泰格医药"},"translate_title":"泰格医药回购54万股A股，自由流通量削减0.08%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03347":1},"content_text":"Hangzhou Tigermed Consulting Co., Ltd. (TIGERMED) disclosed a share repurchase executed on 18 June 2026 via the Shenzhen Stock Exchange, acquiring 542,400 A-shares at prices ranging from RMB 39.33 to RMB 39.98 per share. The volume-weighted average repurchase price was RMB 39.85, bringing total cash outflow to approximately RMB 21.62 million.\nFollowing the transaction, TIGERMED’s outstanding A-shares (excluding treasury shares) decreased by 0.08% from 713.40 million to 712.86 million. Concurrently, treasury shares rose from 24.50 million to 25.04 million, while the company’s total issued share count remained unchanged at 737.90 million.\nThe shares were retained as treasury stock; no cancellations were reported as of the 18 June 2026 closing balance date. The company confirmed that the repurchase complied with Shenzhen Stock Exchange regulations and related Hong Kong Stock Exchange rules governing share buybacks.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}